Prejunctional prostaglandin receptors in the human iris-ciliary body

References

• Westfall T. C. Local regulation of adrenergic neurotransmission. Physiol. Rev. 1977; 57: 659–728
   PubMed Web of Science ®Google Scholar
• Armstrong J. M. Prostaglandins: Pre- and postjunctional modulation of adrenergic nerve function. The Cardiovascular Pharmacology of the Prostaglandins, A. G. Herman, P. M. Vanhoutte, H. Denolin, A. Goosens. Raven Press, New York 1982; 51–64
   Google Scholar
• Malik K. U. Interaction of arachidonic acid metabolites and adrenergic nervous system. Am. J. Med. Sci. 1988; 295: 280–286
   PubMedGoogle Scholar
• Neufeld A. H., Page E. D. Regulation of adrenergic neuromuscular transmission in the rabbit iris. Exp. Eye Res. 1975; 20: 549–561
   PubMed Web of Science ®Google Scholar
• Ohia S. E., Jumblatt J. E. Prejunctional inhibitory effects of prostanoids on sympathetic neurotransmission in the rabbit iris-ciliary body. J. Pharmacol. Exp. Ther. 1990; 255: 11–16
   PubMedGoogle Scholar
• Hedqvist P., Brundin J. Inhibition by prostaglandin E. of noradrenaline release and of effector responses to nerve stimulation in the cat spleen. Life Sci. 1969; 8: 389–395
   PubMedGoogle Scholar
• Hedqvist P. Studies on the effect of prostaglandins E1 and E2 on the sympathetic neuromuscular transmission in the spleen. Acta Physiol. scand. Suppl. 1970; 345: 1–40
   PubMedGoogle Scholar
• Coleman R. A. Methods in prostanoid receptor classification. Prostaglandins and Related Substances: A Practical Approach, C. Benedetto, R. G. Mc Donald-Gibson, S. Nigam, T. F. Slater. IRL Press Limited, Oxford 1987; 267–303
   Google Scholar
• Eglen R. M., Whiting R. L. Classification of prostanoid receptors. CRC Handbook of Eicosanoids: Prostaglandins and Related Lipids. Volume II: Drugs Acting Via the Eicosanoids, A. L. Willis. CRC Press, Inc., Boca Raton 1988; 273–284
   Google Scholar
• Jumblatt J. E., North G. T. Potentiation of sympathetic neurosecretion by forskolin and cyclic AMP in the rabbit iris-ciliary body. Curr. Eye Res. 1986; 5: 495–502
   PubMed Web of Science ®Google Scholar
• Augustine G. J., Charlton M. P., Smith S. J. Calcium action in synaptic transmitter release. Ann. Rev. Neurosci. 1987; 10: 633–693
   PubMed Web of Science ®Google Scholar
• Tsien R. W., Lipscombe D., Madison D. V., Bley K. R., Fox A. P. Multiple types of neuronal calcium channels and their selective modulation. Trends Neurosci. 1988; 11: 431–438
   PubMed Web of Science ®Google Scholar
• Coleman R. A., Kennedy I., Sheldrick R. L. G., Tolowinska I. Y. Further evidence for the existence of three subtypes of PGE -sensitive (EP-) receptors. Br. J. Pharmacol. 1987; 91: 407P
   Google Scholar
• Starke K. Regulation of noradrenaline release by presynaptic receptor systems. Rev. Physiol. Biochem. Pharmacol. 1977; 77: 1–124
   PubMed Web of Science ®Google Scholar
• Rand M. J., Majewski H., Wong-Dusting H., Story D. F., Loiacono R. E., Ziogas J. Modulation of Neuroeffector Transmission. J. Cardiovasc. Pharmacol. 1987; 10(Suppl. 12)S33–-S44
   PubMedGoogle Scholar
• van Alphen G. W. H. M., Wilhelm P. B., Elsenfeld P. B. The effect of prostaglandins on the isolated internal muscles of the mammalian eye, including man. Doc. Ophthalmol. 1977; 42: 397–405
   PubMedGoogle Scholar
• Yoshitomi T., Ito Y. Effects of indomethacin and prostaglandins on the dog iris sphincter and dilator muscles. Invest. Ophthalmol. Vis. Sci. 1988; 29: 127–132
   PubMedGoogle Scholar
• Yousufzai S. Y. K., Chen A. L., Abdel-Latif A. A. Species differences in the effects of prostaglandins on inositol trisphosphate accumulation, phosphatidic acid formation, myosin light chain phosphorylation and contraction in iris sphincter of the mammalian eye: Interaction with the cyclic AMP system. J. Pharmacol. Exp. Ther. 1988; 247: 1064–1072
   PubMed Web of Science ®Google Scholar
• Mittag T. W. Signal transduction systems for prostaglandins in the iris and ciliary body. The Ocular Effects of Prostaglandins and Other Eicosanoids, L. Bito, J. Stjernschantz. Alan R. Liss, Inc., New York 1989; 139–148
   Google Scholar
• Jumblatt M. M., Paterson C. A. Prostaglandin E2 effects on corneal endothelial cyclic adenosine monophosphate synthesis and cell shape are mediated by a receptor of the EP2 subtype. Invest. Ophthalmol. Vis. Sci. 1991; 32: 360–365
   PubMedGoogle Scholar
• Reeves J. J., Bunce K. T., Sheldrick R. L.G., Stables R. Evidence for the PGE receptor subtype mediating inhibition of acid secretion in the rat. Br. J. Pharmacol. 1988; 95: 805P
   PubMedGoogle Scholar
• Yousufzai S. Y. K., Gracy R. A., Aboul-Khair S. H., Abdel-Latif A. A. In vivo electrical stimulation of the sympathetic nerve of the eye increases inositol phosphate production and prostaglandin release in the rabbit iris muscle. J. Neurochem. 1988; 50: 752–758
   PubMedGoogle Scholar
• Yousufzai S. Y. K., Abdel-Latif A. A. Alpha1-adrenergic receptor induced subsensitivity and supersensitivity in rabbit iris-ciliary body. Invest. Ophthalmol. Vis. Sci. 1987; 28: 409–418
   PubMedGoogle Scholar
• Eakins K. E., Whitelocke R. A. F., Bennett A., Martenet A. C. Prostaglandin like activity in ocular inflammation. Br. Med. J. 1972; 3: 452–453
   PubMed Web of Science ®Google Scholar
• Bito L. Z. Prostaglandins, other eicosanoids, and their derivatives as potential antiglaucoma agents. Glaucoma: Applied Pharmacology in Medical Treatment, S. M. Drance, A. H. Neufeld. Grune & Stratton, Inc., Orlando 1984; 477–505
   Google Scholar
• Bito L. Z., Camras C. B., Gum G. G., Resul B. The ocular hypotensive effects and side effects of prostaglandins on the eyes of experimental animals. The Ocular Effects of Prostaglandins and Other Eicosanoids, L. Z. Bito, J. Stjernschantz. Alan R. Liss, Inc., New York 1989; 349–368
   Google Scholar
• Alm A., Villumsen J. Effects of topically applied PGF2α and its isopropylester on normal and glaucomatous human eyes. The Ocular Effects of Prostaglandins and Other Eicosanoids, L. Z. Bito, J. Stjernschantz. Alan R. Liss, Inc., New York 1989; 447–458
   Google Scholar
• Waterbury L. D., Eglen R. M., Faurot G. F., Cooper G. F. EP3 but not EP2 FP, or TP prostanoid-receptor stimulation may reduce intraocular pressure. Invest. Ophthalmol. Vis. Sci. 1990; 31: 2560–2567
   PubMed Web of Science ®Google Scholar
• Woodward D. F., Burke J. A., Fairbairn C. E., Protzman C. E., Shan T., Williams L. S. Marked species differences in the pharmacology of prostanoid induced ocular hypotension. Invest. Ophthalmol. Vis. Sci. 1991; 32: 1257, (Suppl.)
   Google Scholar
• Braslow R. A., Gregory D. S. Adrenergic decentralization modifies the circadian rhythm of intraocular pressure. Invest. Ophthalmol. Vis. Sci. 1987; 28: 1730–1732
   PubMed Web of Science ®Google Scholar
• Smith S. D., Gregory D. S. A circadian rhythm of aqueous flow underlies the circadian rhythm of IOP in NZW rabbits. Invest. Ophthalmol. Vis. Sci. 1989; 10: 775–778
   Google Scholar
• Robinson J. C., Kaufman P. L. Superior cervical ganglionectomy: Effects on aqueous humor flow in the cynomolgus monkey. Invest. Ophthalmol. Vis. Sci. 1991; 32: 788, (Suppl.)
   Google Scholar
• Stone R. A., Kuwayama Y. The nervous system and intraocular pressure. The Glaucomas, R. Rich, M. B. Shields, T. Krupin. C. V. Mosby Company, St. Louis 1989; Volume I: 257–279
   Google Scholar